|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0003595,
umls-concept:C0016030,
umls-concept:C0040715,
umls-concept:C0085151,
umls-concept:C0086418,
umls-concept:C0256371,
umls-concept:C0597298,
umls-concept:C0599718,
umls-concept:C0599813,
umls-concept:C0599893,
umls-concept:C0815000,
umls-concept:C0962722,
umls-concept:C1280500,
umls-concept:C1522702,
umls-concept:C1704241,
umls-concept:C1709694,
umls-concept:C1723136,
umls-concept:C1869507,
umls-concept:C2353566,
umls-concept:C2354310
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2001-4-6
|
|
pubmed:abstractText |
We investigated the effects of different apolipoprotein E (apoE) isoforms, Abeta (1-42), and apoE/Abeta complexes on PKC-alpha translocation and APP processing in human SH-SY5Y neuroblastoma cells and fibroblasts. Treatment of cells with either 10 nM apoE3 or apoE4, 10 microM Abeta (1-42), or apoE/Abeta complexes induced significant translocation of PKC-alpha in both cell types. Effects were seen using both human recombinant apoE and apoE loaded into beta-very low density lipoprotein (beta-VLDL) particles. Time course (5-24 h) studies of APP processing revealed that some conditions induced transient or moderate increases in the secretion of proteins detected by 22C11. In contrast, the secretion of alpha-secretase cleaved APP was either not modified or transiently decreased, as determined by immunoblotting with the antibody 6E10. These results suggest that apoE, Abeta (1-42) and apoE/Abeta complexes can modulate PKC activity but do not have major consequences for APP processing. These effects could contribute to the reported PKC alterations seen in AD. However, it is unlikely that the contribution of different apoE isoforms to AD pathology occurs via effects on APP processing.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0197-0186
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
38
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
615-25
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:11290387-Amyloid beta-Peptides,
pubmed-meshheading:11290387-Amyloid beta-Protein Precursor,
pubmed-meshheading:11290387-Apolipoproteins E,
pubmed-meshheading:11290387-Fibroblasts,
pubmed-meshheading:11290387-Humans,
pubmed-meshheading:11290387-Isoenzymes,
pubmed-meshheading:11290387-Neuroblastoma,
pubmed-meshheading:11290387-Protein Isoforms,
pubmed-meshheading:11290387-Protein Kinase C,
pubmed-meshheading:11290387-Protein Kinase C-alpha,
pubmed-meshheading:11290387-Protein Processing, Post-Translational,
pubmed-meshheading:11290387-Protein Transport,
pubmed-meshheading:11290387-Recombinant Proteins,
pubmed-meshheading:11290387-Tumor Cells, Cultured
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Effects of apolipoprotein E (apoE) isoforms, beta-amyloid (Abeta) and apoE/Abeta complexes on protein kinase C-alpha (PKC-alpha) translocation and amyloid precursor protein (APP) processing in human SH-SY5Y neuroblastoma cells and fibroblasts.
|
|
pubmed:affiliation |
Karolinska Institutet, NEUROTEC, Section for Geriatric Medicine, NOVUM, KFC, plan 4, S-141 86 Huddinge, Sweden.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
